The authors performed immunostaining for ß-amyloid, phosphorylated-tau, and α-synuclein in eyes with glaucoma and in a control group, finding similar levels of expression of ß-amyloid and α-synuclein in both groups, and higher levels of phosphorylated tau protein in glaucomatous eyes. The gene discussed is MAPT; the disease is glaucoma.